Joseph P. Lucia & Associates, LLC Pds Biotechnology Corp Transaction History

Joseph P. Lucia & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$2.28 - $6.81 $91 - $272	-40 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$1.91 - $2.67 $76 - $106	40 New	40 $0
Q3 2020 Oct 20, 2020	SELL	$1.67 - $4.67 $41 - $116	-25 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$0.65 - $2.6 $16 - $65	25 New	25 $0

4.22M

170K

6.7K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $35.3M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.